Scientists from The University of Queensland have discovered two new microorganisms which are said to play an unknown role in greenhouse gas emissions and consumption. [ + ]

TGR BioSciences has announced a European licence agreement with Prime Diagnostics — a developer of high-quality diagnostics, technologies and services for the agricultural sector. [ + ]

Minomic International will next year launch a human study of its monoclonal antibody technology as an imaging agent to detect prostate, pancreatic and bladder cancers. [ + ]

Medlab Clinical has been granted ethics approval to begin two separate human trials using its nanotechnology delivery platform, NanoCelle. The platform, previously developed for cannabis research, converts pharmaceuticals into nanoparticle form. [ + ]

The 2015 Prime Minister's Prizes for Science were awarded on 21 October at a celebratory dinner held at Parliament House. [ + ]

Oxford Nanopore Technologies has developed the MinION, a handheld device that works by detecting individual DNA bases that pass through a nanopore. [ + ]

JDRF has announced a new clinical trial to slow the development of newly diagnosed type 1 diabetes in children. The trial will test a new application of an existing drug currently approved for use in children with juvenile arthritis. [ + ]

Australian scientists have contributed to the worldwide effort of redefining the international unit of temperature: the kelvin. [ + ]

The managing director of Olympus Australia and New Zealand, James Bowe, has made his vision for the company clear, claiming that success is driven by customer relationships. [ + ]

Months after the phenomenon known as 'The Dress' hit the internet, neuroscientists have demonstrated that the optical illusion is linked to specific brain activation patterns. [ + ]

Pharmaceutical company Merck has announced a relaunch of its brand identity in order to reflect its transformation into a global science and technology company. [ + ]

Dr Robert Crombie, the managing director of oncology company Prescient Therapeutics, has resigned in order to focus on other business opportunities. [ + ]

Eli Lilly and Company (Lilly) will terminate its phase 3 trial of the investigational medicine evacetrapib due to insufficient efficacy. [ + ]

Cynata Therapeutics will collaborate with Massachusetts General Hospital on the development of modified mesenchymal stem cells (MSCs) to treat cancer. [ + ]

Promega's PowerPlex Fusion 6C System has been granted approval by the FBI in the United States for use in laboratories that generate DNA records for the National DNA Index System (NDIS). [ + ]